FDA Issues Guidance on Participating in Open Public Hearings at Advisory Committee Meetings

Summary

The Food and Drug Administration (FDA) has released a new guidance document outlining the procedures for the public to participate in open public hearings at FDA advisory committee meetings, including financial disclosure requirements for those involved.